{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T04:37:00Z","timestamp":1776832620763,"version":"3.51.2"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T00:00:00Z","timestamp":1637798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> In the context of the coronavirus disease 2019 (COVID-19) pandemic, the constant needs of people with multiple sclerosis (PwMS) and their caregivers were urgently highlighted.<\/jats:p><jats:p><jats:bold>Aim:<\/jats:bold> The present study aims to capture the effects of the COVID-19 pandemic in several aspects of the quality of life of PwMS, in perception and behavior to COVID-19 and multiple sclerosis (MS), as well as concerning healthcare, working conditions, and the willingness toward COVID-19 vaccination.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> This study is an initiative of the Hellenic Academy of Neuroimmunology (HEL.A.NI.) and it has been included in the MS Data Alliance (MSDA) Catalog, which can be accessed after creating an account on <jats:ext-link>https:\/\/msda.emif-catalogue.eu\/login<\/jats:ext-link>. Two online questionnaires were administered: (i) impact of the COVID-19 pandemic on the quality of life, behavior, and healthcare of PwMS (Questionnaire A) and (ii) vaccination against COVID-19 (Questionnaire B). People with MS were invited to participate by the Hellenic Federation of Persons with Multiple Sclerosis (HFoPwMS).<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Three-hundred-ninety PwMS responded to Questionnaire A, whereas 176 PwMS provided answers for Questionnaire B. Older age, longer disease duration, and higher MS-related disability were associated with the increased perceived sensitivity toward severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, as well as the increased perceived severity of COVID-19 upon potential infection. A significant proportion of PwMS experienced restricted access to MS-related health professionals, disease-modifying therapy (DMT) prescription, and\/or to MS-related laboratory examination due to the pandemic. Subgroups of PwMS reported exacerbated symptoms (i.e., chronic MS-related symptoms, fatigue and\/or worsening of pre-existing fatigue, and sexual dysfunction and or\/worsening of pre-existing sexual dysfunction). Overall, the majority of the participants reported either a strong willingness to get vaccinated against COVID-19 or a likeliness to undergo vaccination. Being aware of the HEL.A.NI. recommendations regarding COVID-19 vaccination for PwMS were reported to increase the willingness of the participants to receive the vaccine.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> Our results highlight the necessity of scientific and patient organizations in taking joint action to increase awareness on health-related issues during the pandemic and to provide accurate and up-to-date guidance for PwMS. Online information and communications technology (ICT) tools for polling public belief and behavior may prove valuable as means of retaining active routes of communication between stakeholders.<\/jats:p>","DOI":"10.3389\/fneur.2021.757038","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T02:16:43Z","timestamp":1638325003000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["A National Representative, Cross-Sectional Study by the Hellenic Academy of NeuroImmunology (HEL.A.NI.) on COVID-19 and Multiple Sclerosis: Overall Impact and Willingness Toward Vaccination"],"prefix":"10.3389","volume":"12","author":[{"given":"Marina","family":"Boziki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charis","family":"Styliadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Bakirtzis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Grigoriadou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aggeliki-Styliani","family":"Sintila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Nikolaidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aliki","family":"Vrienniou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lotte","family":"Geys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sygkliti-Henrietta","family":"Pelidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lesley","family":"Probert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Papazisis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis","family":"Bamidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Grigoriadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1001\/jamaneurol.2020.2581","article-title":"Clinical characteristics and outcomes in patients with coronavirus disease 2019 and multiple sclerosis","volume":"77","author":"Louapre","year":"2020","journal-title":"JAMA Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1177\/1352458520948231","article-title":"Multiple sclerosis management during the COVID-19 pandemic","volume":"26","author":"Moss","year":"2020","journal-title":"Mult Scler."},{"key":"B3","unstructured":"2020"},{"key":"B4","unstructured":"FilippiM\n            HochmeisterS\n            Oreja-GuevaraC\n            TanasescuR\n            WiendlH\n          33051396Immunotherapy for Patients with Neuroimmunological Disorders During the COVID-19 Pandemic2020"},{"key":"B5","unstructured":"MS, the Coronavirus and Vaccines - Updated Global Advice2021"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1177\/1352458520931785","article-title":"Keeping standards of multiple sclerosis care through the COVID-19 pandemic","volume":"26","author":"Sastre-Garriga","year":"2020","journal-title":"Mult Scler."},{"key":"B7","doi-asserted-by":"publisher","first-page":"102642","DOI":"10.1016\/j.msard.2020.102642","article-title":"Fast and safe: optimising multiple sclerosis infusions during COVID-19 pandemic","volume":"47","author":"Rath","year":"2021","journal-title":"Mult Scler Relat Disord."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s10072-020-04391-9","article-title":"Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic","volume":"41","author":"Bonavita","year":"2020","journal-title":"Neurol Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1007\/s10072-020-04470-x","article-title":"Assessing disability and relapses in multiple sclerosis on tele-neurology","volume":"41","author":"Moccia","year":"2020","journal-title":"Neurol Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S1474-4422(20)30147-2","article-title":"An Italian programme for COVID-19 infection in multiple sclerosis","volume":"19","author":"Sormani","year":"2020","journal-title":"Lancet Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1007\/s00415-020-10160-7","article-title":"The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosis","volume":"268","author":"Chiaravalloti","year":"2021","journal-title":"J Neurol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1177\/1355819620975069","article-title":"Impact of the COVID-19 pandemic on persons with multiple sclerosis: early findings from a survey on disruptions in care and self-reported outcomes","volume":"26","author":"Manacorda","year":"2021","journal-title":"J Health Serv Res Policy."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1111\/ene.14580","article-title":"COVID-19 pandemic and mental distress in multiple sclerosis: implications for clinical management","volume":"28","author":"Costabile","year":"2021","journal-title":"Eur J Neurol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"580507","DOI":"10.3389\/fneur.2020.580507","article-title":"The psychological impact of COVID-19 pandemic on people with multiple sclerosis","volume":"11","author":"Motolese","year":"2020","journal-title":"Front Neurol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/S0140-6736(20)30460-8","article-title":"The psychological impact of quarantine and how to reduce it: rapid review of the evidence","volume":"395","author":"Brooks","year":"2020","journal-title":"Lancet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"8202","DOI":"10.3390\/ijerph17218202","article-title":"Physical activity, resilience, sense of coherence and coping in people with multiple sclerosis in the situation derived from COVID-19","volume":"17","author":"Reguera-Garcia","year":"2020","journal-title":"Int J Environ Res Public Health."},{"key":"B17","doi-asserted-by":"publisher","first-page":"102580","DOI":"10.1016\/j.msard.2020.102580","article-title":"Are multiple sclerosis patients and their caregivers more anxious and more committed to following the basic preventive measures during the COVID-19 pandemic?","volume":"46","author":"Talaat","year":"2020","journal-title":"Mult Scler Relat Disord."},{"key":"B18","doi-asserted-by":"publisher","first-page":"102618","DOI":"10.1016\/j.msard.2020.102618","article-title":"Distress and risk perception in people living with multiple sclerosis during the early phase of the COVID-19 pandemic","volume":"47","author":"Alschuler","year":"2021","journal-title":"Mult Scler Relat Disord."},{"key":"B19","doi-asserted-by":"publisher","first-page":"3396","DOI":"10.1111\/ene.14697","article-title":"Perceived stress and social support in a large population of people with multiple sclerosis recruited online through the COVID-19 pandemic","volume":"28","author":"Bonavita","year":"2021","journal-title":"Eur J Neurol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1177\/1352458520941485","article-title":"COVID-19 in people with multiple sclerosis: a global data sharing initiative","volume":"26","author":"Peeters","year":"2020","journal-title":"Mult Scler."},{"key":"B21","doi-asserted-by":"publisher","first-page":"102600","DOI":"10.1016\/j.msard.2020.102600","article-title":"Rapid transfer of knowledge for multiple sclerosis clinical care during COVID-19: ECHO MS","volume":"46","author":"Alschuler","year":"2020","journal-title":"Mult Scler Relat Disord."},{"key":"B22","doi-asserted-by":"publisher","first-page":"577283","DOI":"10.1016\/j.jneuroim.2020.577283","article-title":"Multiple sclerosis and COVID-19: a great opportunity for databases promoting research and collaboration","volume":"345","author":"Racke","year":"2020","journal-title":"J Neuroimmunol."},{"key":"B23","unstructured":"COVID-19 Vaccines Mapping Exercise2021"},{"key":"B24","doi-asserted-by":"crossref","DOI":"10.1201\/9781420028638","volume-title":"Survey Sampling, Theory and Methods","author":"Arijit Chaudhuri","year":"2005"},{"key":"B25","volume-title":"Designing and Conducting Survey Research: A Comprehensive Guide","author":"Louis","year":"2014"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.3389\/fneur.2020.01012","article-title":"The administrative prevalence of multiple sclerosis in greece on the basis of a nationwide prescription database","volume":"11","author":"Bakirtzis","year":"2020","journal-title":"Front Neurol."},{"key":"B27","volume-title":"COVID-19 Snapshot MOnitoring (COSMO Standard): Monitoring Knowledge, Risk Perceptions, Preventive Behavior, and Public Trust in the Current Coronavirus Outbreak - WHO Standard Protocol","year":"2020"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e034869","DOI":"10.1136\/bmjopen-2019-034869","article-title":"Sample study protocol for adapting and translating the 5C scale to assess the psychological antecedents of vaccination","volume":"10","author":"Betsch","year":"2020","journal-title":"BMJ Open."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e030753","DOI":"10.1136\/bmjopen-2019-030753","article-title":"Questionnaire validation practice: a protocol for a systematic descriptive literature review of health literacy assessments","volume":"9","author":"Hawkins","year":"2019","journal-title":"BMJ Open."},{"key":"B30","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.msard.2016.06.011","article-title":"Validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) in Greek population with multiple sclerosis","volume":"9","author":"Polychroniadou","year":"2016","journal-title":"Mult Scler Relat Disord."},{"key":"B31","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3390\/healthcare9070897","article-title":"A greek validation study of the multiple sclerosis work difficulties questionnaire-23","volume":"9","author":"Bakirtzis","year":"2021","journal-title":"Healthcare (Basel)."},{"key":"B32","doi-asserted-by":"publisher","first-page":"102512","DOI":"10.1016\/j.msard.2020.102512","article-title":"Impact of the COVID-19 pandemic on the health care of >1,000 People living with multiple sclerosis: a cross-sectional study","volume":"46","author":"Vogel","year":"2020","journal-title":"Mult Scler Relat Disord."},{"key":"B33","unstructured":"Recommendations for Vaccination Against SARS CoV-2 in Patients with Multiple Sclerosis [text in Greek].2021"},{"key":"B34","doi-asserted-by":"publisher","first-page":"13524585211020435","DOI":"10.1177\/13524585211020435","article-title":"Mental health of people with multiple sclerosis during the COVID-19 outbreak: a prospective cohort and cross-sectional case-control study of the UK MS Register","volume":"3","author":"Garjani","year":"2021","journal-title":"Mult Scler."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e0241103","DOI":"10.1371\/journal.pone.0241103","article-title":"Behavioral practices of patients with multiple sclerosis during Covid-19 pandemic","volume":"15","author":"Alnajashi","year":"2020","journal-title":"PLoS ONE."},{"key":"B36","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3390\/ijerph18010340","article-title":"The impact of the SARS-CoV-2 outbreak on the psychological flexibility and behaviour of cancelling medical appointments of italian patients with pre-existing medical condition: the \u201cImpACT-COVID-19 for Patients\u201d multi-centre observational study","volume":"18","author":"Deledda","year":"2021","journal-title":"Int J Environ Res Public Health."},{"key":"B37","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4172\/pe.1000102","article-title":"Health and economic impact of relapsing forms of multiple sclerosis in Greece: the storms study","volume":"1","author":"Yfantopoulos","year":"2015","journal-title":"Pharmacoeconomics."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e0248892","DOI":"10.1371\/journal.pone.0248892","article-title":"COVID-19 vaccine hesitancy and resistance: correlates in a nationally representative longitudinal survey of the Australian population","volume":"16","author":"Edwards","year":"2021","journal-title":"PLoS ONE."},{"key":"B39","doi-asserted-by":"publisher","first-page":"102788","DOI":"10.1016\/j.msard.2021.102788","article-title":"Willingness to obtain COVID-19 vaccination in adults with multiple sclerosis in the United States","volume":"49","author":"Ehde","year":"2021","journal-title":"Mult Scler Relat Disord."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.757038\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T02:16:49Z","timestamp":1638325009000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.757038\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,25]]},"references-count":39,"alternative-id":["10.3389\/fneur.2021.757038"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.757038","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,25]]},"article-number":"757038"}}